The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment

The roles of M30 and M65 in the assessment of treatment response and prognosis in patients with non-small cell lung cancer, who receive neoadjuvant treatment

Bibliographic Details
Main Authors: Belkıs Coskun, Oguzhan Dizdar, Seniz Korkmaz, Engin Ulukaya, Turkkan Evrensel
Format: Article
Language:English
Published: Termedia Publishing House 2019-12-01
Series:Contemporary Oncology
Subjects:
lung cancer
neoadjuvant treatment
prognosis
cytokeratin
Online Access:https://www.termedia.pl/The-roles-of-M30-and-M65-in-the-assessment-of-treatment-response-and-prognosis-in-patients-with-non-small-cell-lung-cancer-who-receive-neoadjuvant-treatment,3,39554,1,1.html

Internet

https://www.termedia.pl/The-roles-of-M30-and-M65-in-the-assessment-of-treatment-response-and-prognosis-in-patients-with-non-small-cell-lung-cancer-who-receive-neoadjuvant-treatment,3,39554,1,1.html

Similar Items